| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/30/2009 | US7553637 Using expression vector comprising nucleotide sequences coding membrane insertion protein as tool in improving exogenous gene expression in host cells |
| 06/30/2009 | US7553635 Nucleic acids which code for protein from Acremonium chrysogenum; host cells |
| 06/30/2009 | US7553634 Lysis, fermentation, diafiltration |
| 06/30/2009 | US7553631 RBP4 in insulin sensitivity/resistance, diabetes, and obesity |
| 06/30/2009 | US7553630 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |
| 06/30/2009 | US7553617 Fusion proteins of bacteriophage coat proteins, and bacteriophage particles are screened against receptors |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553491 BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 06/30/2009 | US7553490 Use of polysaccharides containing the tetrasaccharide repeat unit to induce serum antibodies having bactericidal activity against hemolytic-uremic syndrome (HUS) causing E. coli, in particular E. coli O157 |
| 06/30/2009 | US7553487 Method and compositions for treating asthma |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2621950A1 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 06/30/2009 | CA2619381A1 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2283356C Methods to diagnose a required regulation of trophoblast invasion |
| 06/30/2009 | CA2259421C Labelling and selection of molecules |
| 06/30/2009 | CA2203480C Interferon conjugates |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2135208C Immunoglobulin binding proteins derived from l protein and their uses |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009079566A2 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 06/25/2009 | WO2009079481A2 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/25/2009 | WO2009079399A2 Method of treating neurodegenerative disease |
| 06/25/2009 | WO2009079210A2 Polypeptides having xylanase activity and polynucleotides encoding same |
| 06/25/2009 | WO2009079053A2 High affinity metal-oxide binding peptides with reversible binding |
| 06/25/2009 | WO2009078977A2 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 06/25/2009 | WO2009078820A1 Cationic core-shell peptide nanoparticles |
| 06/25/2009 | WO2009078799A1 New vaccine for the treatment of mycobacterium related disorders |
| 06/25/2009 | WO2009077744A2 Vaccines for brucellosis |
| 06/25/2009 | WO2009077731A2 Prolactin fusion proteins |
| 06/25/2009 | WO2009077618A2 A host cell deficient for murf1 and murf2 |
| 06/25/2009 | WO2009077577A2 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | WO2009077570A1 Use of fzc18-containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases |
| 06/25/2009 | WO2009077175A1 Polypeptide derived from protein a and able to bind pdgf |
| 06/25/2009 | WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's |
| 06/25/2009 | WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/25/2009 | WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines |
| 06/25/2009 | WO2009058947A3 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 06/25/2009 | WO2009050266A3 Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics |
| 06/25/2009 | WO2009042538A3 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon |
| 06/25/2009 | WO2009036228A3 Hepatitis b pre-s2 nucleic acid |
| 06/25/2009 | WO2009034158A3 Transgenic mice |
| 06/25/2009 | WO2009034041A3 Peptide sequences and compositions |
| 06/25/2009 | WO2009026393A3 Amino acid substituted molecules |
| 06/25/2009 | WO2009023300A3 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 06/25/2009 | WO2009022907A3 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 06/25/2009 | WO2009010733A3 Peptide gap junction modulators |
| 06/25/2009 | WO2009007848A3 Bioactive peptides and method of using same |
| 06/25/2009 | WO2008152527A3 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications. |
| 06/25/2009 | WO2008118015A3 Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants |
| 06/25/2009 | WO2005110461A3 Leptin peptide antagonists |
| 06/25/2009 | WO2005032482A3 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 06/25/2009 | US20090165173 Novel nucleic acid sequences and their use in methods for achieving pathogen resistance in plants |
| 06/25/2009 | US20090165170 Phosphatase Stress-Related Proteins and Methods of Use in Plants |
| 06/25/2009 | US20090165169 regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering; |
| 06/25/2009 | US20090165156 Method for increasing the saltwater tolerance of a fish |
| 06/25/2009 | US20090163438 Gankyrin |
| 06/25/2009 | US20090163424 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 06/25/2009 | US20090163423 Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility |
| 06/25/2009 | US20090163420 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto |
| 06/25/2009 | US20090163415 NT-proBNP, proBNP AND BNP IMMUNOASSAYS, ANTIBODIES AND STABLE STANDARD |
| 06/25/2009 | US20090163413 Dental products comprising bone growth enhancing peptide |
| 06/25/2009 | US20090163410 Novel Peptides and the Biological Use Thereof |
| 06/25/2009 | US20090163409 Trappin-2 (elafin) inhibits HIV |
| 06/25/2009 | US20090163405 Angiogenic peptides and uses thereof |
| 06/25/2009 | US20090163381 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162932 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
| 06/25/2009 | US20090162918 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant |
| 06/25/2009 | US20090162896 Production of Recombinant Collagen Like Proteins |
| 06/25/2009 | US20090162883 Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof |
| 06/25/2009 | US20090162873 Gene encoding a multidrug-resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 06/25/2009 | US20090162869 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 06/25/2009 | US20090162865 northern blotting, electrophoresis, PCR |
| 06/25/2009 | US20090162861 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events |
| 06/25/2009 | US20090162857 Pharmaceutical Compositions and Methods for Delivering Nucleic Acids Into Cells |
| 06/25/2009 | US20090162850 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 06/25/2009 | US20090162847 Rapid detection of the "high-virulent" st-17 clone of group b streptococcus |
| 06/25/2009 | US20090162838 Fluorescence resonance energy transfer enzyme substrates |
| 06/25/2009 | US20090162834 Molecular sequence of swine retrovirus and methods of use |
| 06/25/2009 | US20090162526 Generation of plants with altered oil content |
| 06/25/2009 | US20090162502 Collagen concentrate, use thereof and also process for production thereof |
| 06/25/2009 | US20090162426 Use of a Compound with RANKL Activity |
| 06/25/2009 | US20090162404 Tumor vaccine |
| 06/25/2009 | US20090162402 Immunizing compositions and methods of use |
| 06/25/2009 | US20090162401 Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development |
| 06/25/2009 | US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/25/2009 | US20090162391 Vaccine antigens from piscirickettsia salmonis |
| 06/25/2009 | US20090162390 Molecular Scaffolds for HIV-1 Immunogens |
| 06/25/2009 | US20090162388 epitope of salmonid alphaviruses capable of inducing a virus neutralizing immune response |
| 06/25/2009 | US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor |
| 06/25/2009 | US20090162369 Synthetic chimeric peptides |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |